Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER 2 oncogene alterations-Reference-Cited by-同舟云学术

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER 2 oncogene alterations

Published:2015-12-03 Issue:1 Volume:107 Page:45-52
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Suzawa Ken¹,Toyooka Shinichi¹²³,Sakaguchi Masakiyo⁴,Morita Mizuki³⁵,Yamamoto Hiromasa¹,Tomida Shuta³,Ohtsuka Tomoaki¹,Watanabe Mototsugu¹,Hashida Shinsuke¹²^ORCID,Maki Yuho¹,Soh Junichi¹³,Asano Hiroaki¹,Tsukuda Kazunori¹,Miyoshi Shinichiro¹

Affiliation:

1. Department of Thoracic, Breast and Endocrinological Surgery Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

2. Department of Clinical Genomic Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

3. Department of Biobank Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

4. Department of Cell Biology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

5. Department of Biorepository Research and Networking Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12845

Reference42 articles.

1. The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

2. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

3. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer